FDA statement: Does coffee have to be labeled as a cancer risk?

FDA statement: Does coffee have to be labeled as a cancer risk?

We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.

Dispute over labeling: coffee can cause cancer?

Are coffee drinkers at higher risk of developing cancer? No, says a new study from the World Health Organization. In the USA there is still a lot of discussion about the caffeinated hot beverage. This is about a labeling requirement.

The cause of the debate is a legal dispute in California over the question of whether coffee increases the risk of cancer. The Central Food and Drug Administration (FDA) has now interfered in the dispute. She spoke out against an exemption from the labeling requirement for coffee and thereby agreed with the opinion of California authorities.

In the United States, labeling of carcinogenic ingredients in foods and luxury foods is mandatory. A consumer group had requested that coffee suppliers inform their customers of the carcinogenic chemical acrylamide, which is produced when coffee beans are roasted. A Los Angeles court granted this request in the spring.

A public hearing is now underway in California, after which, on August 30, the state authorities will decide whether to grant coffee an exemption.

The World Health Organization classifies coffee as non-carcinogenic based on a study by its international cancer research agency. The California government therefore wants to exempt substances from coffee roasting from labeling.

The FDA agreed with this opinion. Labeling would only mislead consumers, said agency chief Scott Gottlieb. "We made this decision because we carefully reviewed the latest research on coffee and cancer and they don't support a cancer warning for coffee," he says. (fs)

Author and source information

Video: Ranitidine Recall 2020 - FDA calls for removal of all products due to cancer risk (October 2022).